Jump to ContentJump to Main Navigation
Integrative Neuroscience and Personalized Medicine$
Users without a subscription are not able to see the full content.

Evian Gordon, MD, PhD and Stephen Koslow, PhD

Print publication date: 2010

Print ISBN-13: 9780195393804

Published to Oxford Scholarship Online: January 2011

DOI: 10.1093/acprof:oso/9780195393804.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (www.oxfordscholarship.com). (c) Copyright Oxford University Press, 2019. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a monograph in OSO for personal use (for details see www.oxfordscholarship.com/page/privacy-policy).date: 24 April 2019

Brain-Related Health Care: New Models for Personalized Medicine in Psychiatry

Brain-Related Health Care: New Models for Personalized Medicine in Psychiatry

(p.257) 12 Brain-Related Health Care: New Models for Personalized Medicine in Psychiatry
Integrative Neuroscience and Personalized Medicine

David Whitehouse

Oxford University Press

The healthcare industry and insurers hope that once accurate and effective gene and brain markers of brain disorders are identified and utilized, patient outcomes will be more successful. This is not a panacea for cures, but rather a means of bringing more objective approaches for clinicians to offer patients. Some of these approaches may be more convenient for patients to use, making patients more willing to take control and engage in healthier lifestyles, habits and behaviors, perhaps under the guidance of a health care professional. The applications from Personalized Medicine must be cost effective and result in significant improvement, if not a cure. This chapter will review present practical alternatives to expensive and time-consuming assessments, imaging and laboratory measures. These cost-efficient alternatives will integrate clinical, psychological and neuroscience findings and data, and will use the latest information technology advances for distribution and use by the patient and clinician. This pragmatic context of personalized treatment plans is used in this chapter to emphasize that for reimbursement to occur, validated and robust solutions that are cost-effective will be required as a key factor to accelerate personalized medicine.

Keywords:   phenotype, endophenotype, neuroimaging, WebNeuro, decision-making

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .